Spain Tardive Dyskinesia Market Size & Outlook, 2026-2034

Spain Tardive Dyskinesia Market Insights

According to Reed Intelligence analysis, the Spain Tardive Dyskinesia Market size was USD 75.09 Million in 2025 and is projected to reach USD 183.38 Million by 2034.
The Spain market is projected to grow at a CAGR of 10.4% between 2026 and 2034.
By segment, VMAT2 Inhibitors emerged as the largest Drug Class in terms of market size in 2025.
VMAT2 Inhibitors is anticipated to remain the most attractive Drug Class segment, recording the fastest growth during the forecast period.

Other Key Findings

Spain contributed 2.36% to the global Tardive Dyskinesia Market size in 2025.
By 2034, United States is forecasted to remain the largest global market for Tardive Dyskinesia Market.
In Europe, Germany is projected to capture the leading share of market size by 2034.
Among Europe markets, Benelux is expected to post the fastest growth, reaching USD 119.76 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 75.09 Million
Market Size In 2034	USD 183.38 Million
Largest segment	VMAT2 Inhibitors
Units	Revenue in USD Million
CAGR	10.4% (2026-2034)
Segmnetation Covered
Drug Class	VMAT2 Inhibitors Dopamine Modulators Novel Neuromodulators Supportive Therapies
Distribution Channel	Hospital Pharmacies Retail Pharmacies Specialty Pharmacies Online Pharmacies
End Use	Hospitals Specialty Clinics Homecare Settings Rehabilitation Centers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Spain Tardive Dyskinesia Market Drug Class 2026-2034 (USD Million)

Drug Class	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
VMAT2 Inhibitors	XX.x	XX.x	XX.x	31.02	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dopamine Modulators	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Novel Neuromodulators	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Supportive Therapies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Spain Tardive Dyskinesia Market Distribution Channel 2026-2034 (USD Million)

Distribution Channel	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospital Pharmacies	XX.x	XX.x	XX.x	33.6	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Retail Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Spain Tardive Dyskinesia Market End Use 2026-2034 (USD Million)

End Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	XX.x	XX.x	XX.x	36.21	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Homecare Settings	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Rehabilitation Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.